Published: May 2011
No. of Pages: 110
Price: $ 3400
The European market for medical imaging equipment continues to thrive despite the impact of a global economic recession. As such, the European medical imaging market represents a dynamic and robust sector which will progressively represent an increasingly important sub-market within the medical device business. In order to provide a comprehensive and relevant analysis of the European medical imaging market, this TriMark Publications report covers the major medical imaging modalities of computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), single photon emission computed tomography (SPECT) and ultrasound. In order to reflect the ongoing shifts in the utilization of the modalities from single to multimodality systems, this study also includes analyzes of the European markets for PET/CT and SPECT/CT.
Browse All: Pharmaceutical Market Research
While the European medical imaging market is dominated by a handful of multinational players, this report surveys almost all of the companies known to be marketing, manufacturing or developing medical imaging equipment and supplies in France, Germany, Italy, Spain, the United Kingdom, the Benelux countries, Scandinavia and the rest of Europe (ROE). Each company is discussed in extensive depth with a section on its history, product line, business and marketing analysis, and a subjective commentary of the company’s market position. Detailed tables and charts with sales forecasts and market data are also included. To complete the analysis of the European market, this report also reviews other factors which are instrumental in shaping the future direction of Europe's medical imaging sector. The study looks at pricing, reimbursement issues, provides an assessment of the purchasing processes for capital equipment in each target market, and reviews alternative funding methods for capital equipment purchases and the regulatory environment with its inherent issues and challenges.
No. of Pages: 110
Price: $ 3400
The European market for medical imaging equipment continues to thrive despite the impact of a global economic recession. As such, the European medical imaging market represents a dynamic and robust sector which will progressively represent an increasingly important sub-market within the medical device business. In order to provide a comprehensive and relevant analysis of the European medical imaging market, this TriMark Publications report covers the major medical imaging modalities of computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), single photon emission computed tomography (SPECT) and ultrasound. In order to reflect the ongoing shifts in the utilization of the modalities from single to multimodality systems, this study also includes analyzes of the European markets for PET/CT and SPECT/CT.
Browse All: Pharmaceutical Market Research
While the European medical imaging market is dominated by a handful of multinational players, this report surveys almost all of the companies known to be marketing, manufacturing or developing medical imaging equipment and supplies in France, Germany, Italy, Spain, the United Kingdom, the Benelux countries, Scandinavia and the rest of Europe (ROE). Each company is discussed in extensive depth with a section on its history, product line, business and marketing analysis, and a subjective commentary of the company’s market position. Detailed tables and charts with sales forecasts and market data are also included. To complete the analysis of the European market, this report also reviews other factors which are instrumental in shaping the future direction of Europe's medical imaging sector. The study looks at pricing, reimbursement issues, provides an assessment of the purchasing processes for capital equipment in each target market, and reviews alternative funding methods for capital equipment purchases and the regulatory environment with its inherent issues and challenges.
No comments:
Post a Comment